Baxter International | BAX - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 16.15B 1.66B 2026-09
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 76.66M 30.28M 2026-09
AtriCure USD 83.97M 2.06M 2026-09
Baxter International USD 3.81B 218M 2026-09
Becton, Dickinson and Co. USD 9.54B 139M 2026-09
Boston Scientific USD 5.98B 446M 2026-09
Cooper Companies USD 1.87B 61.9M 2026-06
Dexcom USD 2.25B 105.1M 2026-09
Edwards Lifesciences USD 1.58B 68.8M 2026-09
Fresenius EUR 8.08B 986M 2026-09
Globus Medical USD 507.94M 28.59M 2026-09
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
ICU Medical USD 514.63M 16.27M 2026-09
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 814.4M 70.2M 2026-09
Integra LifeSciences USD 329M 1.88M 2026-09
Intuitive Surgical USD 3.23B 652.4M 2026-09
J&J USD 55.46B 562M 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Medtronic USD 11.8B 141M 2026-06
Merit Medical Systems USD 265.08M 150K 2026-09
Quest Diagnostics USD 1.83B 46M 2026-09
Smith & Nephew USD 2.05B 510M 2026-06
Stryker USD 6.5B 184M 2026-09
Tandem Diabetes Care USD 256.08M 3.07M 2026-09
Teleflex USD 917.1M 196.72M 2026-09
Terumo JPY 413.28B 127.46B 2026-06
Zimmer Biomet Holdings USD 3.5B 488.9M 2026-09